» Articles » PMID: 35163583

Differential Expression of Serum Extracellular Vesicle MiRNAs in Multiple Sclerosis: Disease-Stage Specificity and Relevance to Pathophysiology

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Feb 15
PMID 35163583
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system (CNS). Its first clinical presentation (clinically isolated syndrome, CIS) is often followed by the development of relapsing-remitting MS (RRMS). The periphery-to-CNS transmission of inflammatory molecules is a major pathophysiological pathway in MS. This could include signalling via extracellular vesicle (EV) microRNAs (miRNAs). In this study, we investigated the serum EV miRNome in CIS and RRMS patients and matched controls, with the aims to identify MS stage-specific differentially expressed miRNAs and investigate their biomarker potential and pathophysiological relevance. miRNA sequencing was conducted on serum EVs from CIS-remission, RRMS-relapse, and viral inflammatory CNS disorder patients, as well as from healthy and hospitalized controls. Differential expression analysis was conducted, followed by predictive power and target-pathway analysis. A moderate number of dysregulated serum EV miRNAs were identified in CIS-remission and RRMS-relapse patients, especially relative to healthy controls. Some of these miRNAs were also differentially expressed between the two MS stages and had biomarker potential for patient-control and CIS-RRMS separations. For the mRNA targets of the RRMS-relapse-specific EV miRNAs, biological processes inherent to MS pathophysiology were identified using in silico analysis. Study findings demonstrate that specific serum EV miRNAs have MS stage-specific biomarker potential and contribute to the identification of potential targets for novel, efficacious therapies.

Citing Articles

Extracellular vesicles as standard-of-care therapy: will fast-tracking the regulatory processes help achieve the goal?.

Kale V Regen Med. 2024; 19(12):617-635.

PMID: 39688586 PMC: 11730413. DOI: 10.1080/17460751.2024.2442847.


A critical systematic review of extracellular vesicle clinical trials.

Mizenko R, Feaver M, Bozkurt B, Lowe N, Nguyen B, Huang K J Extracell Vesicles. 2024; 13(10):e12510.

PMID: 39330928 PMC: 11428870. DOI: 10.1002/jev2.12510.


Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases.

Zanirati G, Dos Santos P, Alcara A, Bruzzo F, Ghilardi I, Wietholter V Int J Mol Sci. 2024; 25(13).

PMID: 39000479 PMC: 11242541. DOI: 10.3390/ijms25137371.


Exploring miRNAs' Based Modeling Approach for Predicting PIRA in Multiple Sclerosis: A Comprehensive Analysis.

Gosetti di Sturmeck T, Malimpensa L, Ferrazzano G, Belvisi D, Leodori G, Lembo F Int J Mol Sci. 2024; 25(12).

PMID: 38928049 PMC: 11203572. DOI: 10.3390/ijms25126342.


Perspective and Therapeutic Potential of the Noncoding RNA-Connexin Axis.

Li X, Wang Z, Chen N Int J Mol Sci. 2024; 25(11).

PMID: 38892334 PMC: 11173347. DOI: 10.3390/ijms25116146.


References
1.
Teunissen C, Petzold A, Bennett J, Berven F, Brundin L, Comabella M . A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009; 73(22):1914-22. PMC: 2839806. DOI: 10.1212/WNL.0b013e3181c47cc2. View

2.
Thompson A, Baranzini S, Geurts J, Hemmer B, Ciccarelli O . Multiple sclerosis. Lancet. 2018; 391(10130):1622-1636. DOI: 10.1016/S0140-6736(18)30481-1. View

3.
Thompson A, Banwell B, Barkhof F, Carroll W, Coetzee T, Comi G . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017; 17(2):162-173. DOI: 10.1016/S1474-4422(17)30470-2. View

4.
Ebrahimkhani S, Vafaee F, Young P, Hur S, Hawke S, Devenney E . Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci Rep. 2017; 7(1):14293. PMC: 5662562. DOI: 10.1038/s41598-017-14301-3. View

5.
Squadrito M, Baer C, Burdet F, Maderna C, Gilfillan G, Lyle R . Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Rep. 2014; 8(5):1432-46. DOI: 10.1016/j.celrep.2014.07.035. View